UNICREDIT BANK/CALL/ABBVIE/150/0.1/18.12.24 Share Price

Warrant

DE000HC3LG51

Market Closed - BOERSE MUENCHEN 01:11:31 15/06/2024 am IST
2.24 EUR +9.80% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/150/0.1/18.12.24
Current month+46.41%
1 month+30.23%
Date Price Change
14/24/14 2.24 +9.80%
13/24/13 2.04 +3.55%
12/24/12 1.97 -7.94%
11/24/11 2.14 -7.36%
10/24/10 2.31 +1.32%

Real-time BOERSE MUENCHEN

Last update June 15, 2024 at 01:11 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3LG5
ISINDE000HC3LG51
Date issued 27/01/2023
Strike 150 $
Maturity 18/12/2024 (185 Days)
Parity 10 : 1
Emission price 1.95
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.46
Lowest since issue 0.83
Delta0.77x
Omega 5.532
Premium2.98x
Gearing7.14x
Moneyness 1.124
Difference Strike -18.59 $
Difference Strike %-12.39%
Spread 0.01
Spread %0.45%
Theoretical value 2.205
Implied Volatility 24.89 %
Total Loss Probability 26.65 %
Intrinsic value 1.736
Present value 0.4685
Break even 173.61 €
Theta-0.02x
Vega0.03x
Rho0.05x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
168.6 USD
Average target price
183 USD
Spread / Average Target
+8.57%
Consensus